--- title: "Why Programmatic Ad Spend Doesn't Predict Signed Retainers" url: https://www.masstortmarketingagency.com/blogs/ad-spend-vs-signed-retainers canonical: https://www.masstortmarketingagency.com/blogs/ad-spend-vs-signed-retainers published: 2026-05-20 modified: 2026-05-20 author: name: Tarun role: Founder, Mass Tort Agency publisher: name: Mass Tort Agency url: https://www.masstortmarketingagency.com description: | Mass tort and PI marketing agencies lead with cumulative ad-spend figures — $250M, $500M, $1B+ deployed. The metric makes for great pitch decks and explains almost nothing about whether a specific firm will sign retainers. The math behind why, the five variables ad spend is silent on, and the procurement-grade metrics to demand instead. keywords: - ad spend vs signed retainers - cost per signed retainer - mass tort marketing metrics - plaintiff acquisition procurement - MVA lead vendor vetting - state-specific CPSR license: | Cite freely with attribution to Mass Tort Agency. Verbatim quoting permitted with citation back to the canonical URL. --- # Why programmatic ad spend doesn't predict signed retainers > **Quick answer.** Run the category's own headline math: $250M deployed > ÷ 2M leads generated = $125 average cost per lead. At the industry's > 3–8% lead-to-signed-retainer conversion (midpoint ~5.5%), 2M leads > yield ~110,000 signed retainers across 15+ years — divided by 600 > firms served, roughly 183 retainers per firm over the relationship > lifetime, or 60–90 per firm per year. Cumulative ad spend describes > what a vendor did across all clients, not what it will do for your > firm. The procurement metric that matters is state-specific cost per > signed retainer, which ranges from $1,400 in Georgia to $4,500 in > California for MVA leads. ## The pitch deck Open any mass tort marketing agency's homepage in 2026 and you'll see a variation of the same three numbers formatted as a hero band: - **$250 million** in ad spend deployed - **600+** law firms served - **2 million** leads generated The numbers vary by agency; the format doesn't. Scale does matter — a vendor that has run $250M through Meta knows things a $25M vendor doesn't, and publisher relationships, consent tooling, and intake training compound with volume. But cumulative ad spend, lead count, and firm count share a structural problem as procurement metrics: **they describe what the vendor has done across all clients, not what they will do for your firm.** ## The math nobody puts on the pitch deck - Average cost per lead across the category: **$250M ÷ 2M = $125 per lead** — a reasonable industry-wide CPL for paid Meta plaintiff acquisition across mass tort, MVA, and general PI. - Lead-to-signed-retainer conversion for paid social runs **3% to 8%** depending on tort, vendor sophistication, intake quality, and case-management speed. Industry midpoint: **~5.5%**. - 2 million leads × 5.5% = **110,000 signed retainers** across 15+ years. Divided by 600 firms = ~183 signed retainers per firm over the relationship lifetime — over a typical 2–3 year engagement, **60–90 retainers per firm per year**. For some firms that's the entire docket; for others, a rounding error. The procurement-relevant question is not cumulative lead volume — it's the per-signed-retainer cost for a firm with your specific docket mix. ## What ad spend doesn't tell you ### 1. State-specific qualification difficulty $250M at $125 average CPL doesn't tell you whether the vendor prices in North Carolina's pure contributory negligence rule, Florida's post-SB 236 modified-51% comparative bar, Tennessee's 1-year statute of limitations, or California's PROP 213 non-economic-damage bar on uninsured claimants. The cumulative figure averages all of this away. Mass Tort Agency's [State Qualification Index™](https://www.masstortmarketingagency.com/tools/state-qualification-index) scores 25 states across five qualification axes; the spread between the highest-difficulty state (North Carolina, 7.6/10) and the lowest (Massachusetts, 3.2/10) is wider than any national-CPL number can capture. ### 2. Tort-mix concentration A vendor's $250M lifetime spend might be 80% Camp Lejeune, 15% Roundup, and 5% everything else. If you're launching a Suboxone or Depo-Provera campaign, deep expertise in two settled-or-settling MDLs doesn't transfer cleanly — NEC baby formula intake scripts don't work for hair relaxer cases. Ask: *"What percentage of your last 12 months of ad spend was in the tort I'm launching, and what was the per-tort CPSR?"* ### 3. Vintage of the operational playbook Meta's ad platform in 2018 is not Meta's in 2026. iOS 14.5 attribution blackout, Apple Mail Privacy Protection, consent-mode-v2 EU rules, and the Aleo privacy framework on Android have forced paid plaintiff acquisition to be re-engineered multiple times in four years. A "$250M deployed since 2015" figure compounds spend from very different operating environments — the first $50M was likely far cheaper per qualified conversion than the last $50M. ### 4. Intake team and case-management quality Lead-to-signed-retainer conversion is a function of lead quality (vendor-controlled), intake responsiveness (vendor- or firm-controlled), and case-management velocity (firm-controlled). A 7-minute speed-to-call vendor with a trained qualifying specialist outperforms a 4-hour generic intake handoff by 30–50%. Ad-spend figures don't reveal which side of that equation the vendor is on. ### 5. Attribution honesty "2 million leads generated" is defensible only if "lead" is generously defined — accidental clicks, unqualified submissions, and competing-firm scrubs included. Aggregate stats average the worst and best clients together; your outcome lands closer to one extreme, never the middle. ## What you should be measuring instead ### Cost per signed retainer (CPSR), per state Not national average — per state, per tort, across your peer set. CPSR is the only metric that includes media cost, intake cost, qualification cost, and signed-retainer attribution loss. Mass Tort Agency publishes state-specific MVA CPSR benchmarks in [MVA CPSR by State 2026](https://www.masstortmarketingagency.com/blogs/mva-cpsr-by-state-2026): the range across 25 covered states is **$1,400 in Georgia to $4,500 in California**. A national CPSR average hides $3,000+ of state-arbitrage variance per signed retainer. ### Intake-to-signed-retainer rate, per tort A vendor running 4% intake-to-sign on Camp Lejeune and 12% on AFFF is showing you their playbook's vintage. The right benchmark is "your tort, last 90 days," not "all torts, all time." ### Speed-to-call SLA Live-transfer vendors should commit to under-4-minute SLAs for inbound qualified callers. Anything slower hemorrhages signed retainers to faster-responding competitors. Binary procurement question. ### State-bar advertising compliance posture In Louisiana, Texas, and New York this matters more than CPL. Vendors without state-bar-filed advertising records create direct exposure for the firm using their leads. Ask for the bar-filing documentation; if they don't have it, walk. ### Post-sign attribution honesty Does the vendor reconcile signed retainers back to specific leads, with a clear definition of what counts as "their" retainer? The most common manipulation is claiming credit for retainers signed on leads already in the firm's pipeline. Demand a clawback clause for double-attributed retainers. ## The two-category framing Cumulative ad-spend figures are useful when selecting a **volume marketing agency** — firms whose pitch is "we've done this at scale," best fit for established PI firms with mature intake spending $50K–$200K/month who want one vendor managing the paid layer. They're irrelevant when selecting a **procurement-grade analyst agency** — firms whose metrics are state-specific CPSR, per-tort intake-to-sign rates, bar-compliance records, and attribution honesty, best fit for mid-size to large PI firms expanding across states, launching new torts, or replacing a vendor after being burned by national-average pricing. Neither category is "better"; the mistake is evaluating every vendor by the volume agency's pitch metrics when your decision is an analyst-category decision. ## A simple procurement test Before signing with any mass tort or MVA lead vendor: 1. **Ask for state-specific CPL.** "We don't price by state" or "our national average is $X" means a volume agency. Decide if that's what you want. 2. **Ask about contributory-negligence states.** "How do you qualify leads differently in North Carolina vs Georgia?" A vendor who can't articulate the contributory-vs-modified-50 difference shouldn't sell you NC leads. 3. **Ask for state-bar compliance documentation.** "Show me the Louisiana Bar Lawyer Advertising Committee pre-approval records for your LA-facing ads." Most vendors don't have this. 4. **Ask for tort-specific intake-to-sign rates from the last 90 days.** Cumulative or all-tort averages mean the data infrastructure isn't there. 5. **Ask about post-sign attribution.** Weekly reconciliation of signed retainers to specific leads, plus a double-attribution clawback clause. A vendor who passes all five is procurement-grade. One or two passes means a volume agency — fine, if that's what you want. ## What we measure ourselves on Mass Tort Agency leads with state-specific CPSR benchmarks, tort-specific intake-to-sign rates, the State Qualification Index™ scoring all 25 covered states, and bar-advertising compliance documentation — and publishes CPSR ranges publicly. Cumulative ad spend is real; it just isn't the right number to evaluate any vendor on. Your procurement decision is specific to your state coverage, tort mix, intake operation, and case-management velocity. Demand vendor metrics that match. Related tools and analysis: - State Qualification Index™: https://www.masstortmarketingagency.com/tools/state-qualification-index - MVA Case Value Estimator: https://www.masstortmarketingagency.com/tools/mva-case-value-estimator - MVA CPSR by State 2026: https://www.masstortmarketingagency.com/blogs/mva-cpsr-by-state-2026